155 related articles for article (PubMed ID: 23474215)
1. 26- and 27-Methyl groups of 2-substituted, 19-nor-1α,25-dihydroxylated vitamin D compounds are essential for calcium mobilization in vivo.
Grzywacz P; Plum LA; Clagett-Dame M; DeLuca HF
Bioorg Chem; 2013 Apr; 47():9-16. PubMed ID: 23474215
[TBL] [Abstract][Full Text] [Related]
2. 26-Desmethyl-2-methylene-22-ene-19-nor-1α,25-dihydroxyvitamin D3 compounds selectively active on intestine.
Chiellini G; Grzywacz P; Plum LA; Clagett-Dame M; DeLuca HF
Steroids; 2014 May; 83():27-38. PubMed ID: 24513051
[TBL] [Abstract][Full Text] [Related]
3. Systematic studies on synthesis, structural elucidation, and biological evaluation of A-ring diastereomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and 20-epi-2-methyl-1alpha,25-dihydroxyvitamin D(3).
Takayama H; Konno K; Fujishima T; Maki S; Liu Z; Miura D; Chokki M; Ishizuka S; Smith C; DeLuca HF; Nakagawa K; Kurobe M; Okano T
Steroids; 2001; 66(3-5):277-85. PubMed ID: 11179735
[TBL] [Abstract][Full Text] [Related]
4. Removal of the 26-methyl group from 19-nor-1α,25-dihydroxyvitamin D₃ markedly reduces in vivo calcemic activity without altering in vitro VDR binding, HL-60 cell differentiation, and transcription.
Grzywacz P; Chiellini G; Plum LA; Clagett-Dame M; DeLuca HF
J Med Chem; 2010 Dec; 53(24):8642-9. PubMed ID: 21105677
[TBL] [Abstract][Full Text] [Related]
5. The antagonism between 2-methyl-1,25-dihydroxyvitamin D3 and 2-methyl-20-epi-1,25-dihydroxyvitamin D3 in non-genomic pathway-mediated biological responses induced by 1alpha,25-dihydroxyvitamin D3 assessed by NB4 cell differentiation.
Miura D; Norman AW; Mizwicki MT; Fujishima T; Konno K; Kittaka A; Takayama H; Ishizuka S
J Steroid Biochem Mol Biol; 2005 Apr; 94(5):469-79. PubMed ID: 15876412
[TBL] [Abstract][Full Text] [Related]
6. Analogs of 1alpha,25-dihydroxyvitamin D3 with high potency in induction of osteoclastogenesis and prevention of dendritic cell differentiation: synthesis and biological evaluation of 2-substituted 19-norvitamin D analogs.
Shimazaki M; Miyamoto Y; Yamamoto K; Yamada S; Takami M; Shinki T; Udagawa N; Shimizu M
Bioorg Med Chem; 2006 Jul; 14(13):4645-56. PubMed ID: 16513359
[TBL] [Abstract][Full Text] [Related]
7. Novel ring A stereoisomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and 2-methyl-20-epi-1alpha,25-dihydroxyvitamin D(3): transactivation of target genes and modulation of differentiation in human promyelocytic leukemia (HL-60) cells.
Nakagawa K; Kurobe M; Ozono K; Konno K; Fujishima T; Takayama H; Okano T
Biochem Pharmacol; 2000 Mar; 59(6):691-702. PubMed ID: 10677586
[TBL] [Abstract][Full Text] [Related]
8. New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues.
Sicinski RR; Prahl JM; Smith CM; DeLuca HF
J Med Chem; 1998 Nov; 41(23):4662-74. PubMed ID: 9804706
[TBL] [Abstract][Full Text] [Related]
9. In vitro biological activities of a series of 2 beta-substituted analogues of 1 alpha,25-dihydroxyvitamin D3.
Tsugawa N; Nakagawa K; Kurobe M; Ono Y; Kubodera N; Ozono K; Okano T
Biol Pharm Bull; 2000 Jan; 23(1):66-71. PubMed ID: 10706413
[TBL] [Abstract][Full Text] [Related]
10. A Methylene Group on C-2 of 24,24-Difluoro-19-nor-1α,25-dihydroxyvitamin D3 Markedly Increases Bone Calcium Mobilization in Vivo.
Flores A; Massarelli I; Thoden JB; Plum LA; DeLuca HF
J Med Chem; 2015 Dec; 58(24):9731-41. PubMed ID: 26630444
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of 2α-[2-(tetrazol-2-yl)ethyl]-1α,25-dihydroxyvitamin D
Yasuda K; Tohyama E; Takano M; Kittaka A; Ohta M; Ikushiro S; Sakaki T
J Steroid Biochem Mol Biol; 2018 Apr; 178():333-339. PubMed ID: 29425808
[TBL] [Abstract][Full Text] [Related]
12. New highly calcemic 1 alpha,25-dihydroxy-19-norvitamin D(3) compounds with modified side chain: 26,27-dihomo- and 26,27-dimethylene analogs in 20S-series.
Sicinski RR; Prahl JM; Smith CM; DeLuca HF
Steroids; 2002 Mar; 67(3-4):247-56. PubMed ID: 11856548
[TBL] [Abstract][Full Text] [Related]
13. Removal of the 20-methyl group from 2-methylene-19-nor-(20S)-1alpha,25-dihydroxyvitamin D(3) (2MD) selectively eliminates bone calcium mobilization activity.
Barycki R; Sicinski RR; Plum LA; Grzywacz P; Clagett-Dame M; Deluca HF
Bioorg Med Chem; 2009 Nov; 17(22):7658-69. PubMed ID: 19819702
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological studies of the A-ring-modified 1,25-dihydroxyvitamin D3 analogs.
Takayama H; Kittaka A; Fujishima T; Suhara Y
Recent Results Cancer Res; 2003; 164():289-317. PubMed ID: 12899530
[TBL] [Abstract][Full Text] [Related]
15. Biological activities of 2alpha-substituted analogues of 1alpha,25-dihydroxyvitamin D3 in transcriptional regulation and human promyelocytic leukemia (HL-60) cell proliferation and differentiation.
Takahashi E; Nakagawa K; Suhara Y; Kittaka A; Nihei K; Konno K; Takayama H; Ozono K; Okano T
Biol Pharm Bull; 2006 Nov; 29(11):2246-50. PubMed ID: 17077522
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation, and conformational analysis of A-ring diastereomers of 2-methyl-1,25-dihydroxyvitamin D(3) and their 20-epimers: unique activity profiles depending on the stereochemistry of the A-ring and at C-20.
Konno K; Fujishima T; Maki S; Liu Z; Miura D; Chokki M; Ishizuka S; Yamaguchi K; Kan Y; Kurihara M; Miyata N; Smith C; DeLuca HF; Takayama H
J Med Chem; 2000 Nov; 43(22):4247-65. PubMed ID: 11063621
[TBL] [Abstract][Full Text] [Related]
17. Singly dehydroxylated A-ring analogues of 19-nor-1alpha,25-dihydroxyvitamin D3 and 19-nor-22-oxa-1alpha,25-dihydroxyvitamin D3: novel vitamin D3 analogues with potent transcriptional activity but extremely low affinity for vitamin D receptor.
Okano T; Nakagawa K; Tsugawa N; Ozono K; Kubodera N; Osawa A; Terada M; Mikami K
Biol Pharm Bull; 1998 Dec; 21(12):1300-5. PubMed ID: 9881643
[TBL] [Abstract][Full Text] [Related]
18. Selective analogs of 1alpha,25-dihydroxyvitamin D3 for the study of specific functions of Vitamin D.
DeLuca HF; Plum LA; Clagett-Dame M
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):263-8. PubMed ID: 17241781
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activity of 1α,2α,25-trihydroxyvitamin D3: active metabolite of 2α-(3-hydroxypropoxy)-1α,25-dihydroxyvitamin D3 by human CYP3A4.
Takano M; Ohya S; Yasuda K; Nishikawa M; Takeuchi A; Sawada D; Sakaki T; Kittaka A
Chem Pharm Bull (Tokyo); 2014; 62(2):182-4. PubMed ID: 24492588
[TBL] [Abstract][Full Text] [Related]
20. Antagonistic action of novel 1alpha,25-dihydroxyvitamin D3-26, 23-lactone analogs on differentiation of human leukemia cells (HL-60) induced by 1alpha,25-dihydroxyvitamin D3.
Miura D; Manabe K; Ozono K; Saito M; Gao Q; Norman AW; Ishizuka S
J Biol Chem; 1999 Jun; 274(23):16392-9. PubMed ID: 10347199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
